Anzeige
Mehr »
Mittwoch, 25.06.2025 - Börsentäglich über 12.000 News
TAO +1.800?%, SBAR +85?%, CYK +280?% - jetzt startet KORA auf Unternehmensebene durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 882807 | ISIN: US92532F1003 | Ticker-Symbol: VX1
Tradegate
25.06.25 | 12:56
389,10 Euro
+0,37 % +1,45
1-Jahres-Chart
VERTEX PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
VERTEX PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
386,80388,8514:00
386,80389,7014:01

Aktuelle News zur VERTEX PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiADA: Vertex closer to weaning type 1 diabetics off insulin9
MoVertex Pharma's Type 1 Diabetes Cell Therapy Shows Potential to Achieve Insulin Independence29
MoVertex's remaining islet cell therapy reduces dangerously low blood sugar levels in phase 1/2 test15
MoVertex and Ono Pharmaceutical form exclusive alliance for Povetacicept in Japan and South Korea15
VERTEX PHARMACEUTICALS Aktie jetzt für 0€ handeln
SaVertex bei ADA 85. Wissenschaftstagung: Vielversprechender Durchbruch bei Diabetes24
SaVertex posts additional trial data for type 1 diabetes therapy22
FrVertex (VRTX) Stock PT Lowered to $420 on slower Alyftrek Uptake7
18.06.Vertex Pharmaceuticals (VRTX) Soared as Investors Back Strategic Initiatives29
17.06.A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 10 Analysts13
11.06.Vertex lays off 125 staffers, slims Rhode Island campus after ditching failed diabetes cell-device combo13
10.06.$1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth This Much Today6
09.06.How Is Vertex Pharmaceuticals' Stock Performance Compared to Other Biotech Stocks?10
06.06.Vertex Pharmaceuticals Incorporated: Vertex Presents New Data on Benefits of ALYFTREK and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference402- Oral presentation on outcomes following treatment with CFTR modulators show that improvements in CFTR function, as measured by lower sweat chloride, correlate with better outcomes for people with...
► Artikel lesen
28.05.Lilly takes on Vertex in non-opioid pain with SiteOne buy36
28.05.3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow29
27.05.Eli Lilly Commits $1B to Get Drug That Could Rival Vertex's New Non-Opioid Pain Med18
27.05.Lilly to buy pain drug developer SiteOne, challenging Vertex15
21.05.Vertex Pharmaceuticals Stock Outlook: Is Wall Street Bullish or Bearish?19
20.05.Vertex Pharma announces new share buybacks worth up to $4B32
14.05.VERTEX PHARMACEUTICALS INC / MA - 8-K, Current Report26
Weiter >>
190 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,3,12